Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
Hayley Donnella(University of California, San Francisco), Sourav Bandyopadhyay(University of California, San Francisco), Roman Camarda(University of California, San Francisco), Olga Momčilović(University of California, San Francisco), James E. Korkola(Oregon Health & Science University), John D. Gordan(University of California, San Francisco), Andrei Goga(University of California, San Francisco), James T. Webber(UCSF Helen Diller Family Comprehensive Cancer Center), Kevan M. Shokat(Howard Hughes Medical Institute), Rebecca S. Levin(University of California, San Francisco), Nora Bayani(Lawrence Berkeley National Laboratory), Khyati N. Shah(Pfizer (United States))
Cited by 92
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k